Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 32


Randomized trial finds that prostate cancer genetic risk score feedback targets prostate-specific antigen screening among at-risk men.

Turner AR, Lane BR, Rogers D, Lipkus I, Weaver K, Danhauer SC, Zhang Z, Hsu FC, Noyes SL, Adams T, Toriello H, Monroe T, McKanna T, Young T, Rodarmer R, Kahnoski RJ, Tourojman M, Kader AK, Zheng SL, Baer W, Xu J.

Cancer. 2016 Jul 19. doi: 10.1002/cncr.30162. [Epub ahead of print]


Critical appraisal of first-generation renal tumor complexity scoring systems: Creation of a second-generation model of tumor complexity.

Tobert CM, Shoemaker A, Kahnoski RJ, Lane BR.

Urol Oncol. 2015 Apr;33(4):167.e1-6. doi: 10.1016/j.urolonc.2014.12.016. Epub 2015 Feb 7.


Exome-wide Sequencing Shows Low Mutation Rates and Identifies Novel Mutated Genes in Seminomas.

Cutcutache I, Suzuki Y, Tan IB, Ramgopal S, Zhang S, Ramnarayanan K, Gan A, Lee HH, Tay ST, Ooi A, Ong CK, Bolthouse JT, Lane BR, Anema JG, Kahnoski RJ, Tan P, Teh BT, Rozen SG.

Eur Urol. 2015 Jul;68(1):77-83. doi: 10.1016/j.eururo.2014.12.040. Epub 2015 Jan 14.


Surgeon assessment of renal preservation with partial nephrectomy provides information comparable to measurement of volume preservation with 3-dimensional image analysis.

Tobert CM, Boelkins B, Culver S, Mammen L, Kahnoski RJ, Lane BR.

J Urol. 2014 May;191(5):1218-24. doi: 10.1016/j.juro.2013.11.003. Epub 2013 Nov 7.


Differential use of partial nephrectomy for intermediate and high complexity tumors may explain variability in reported utilization rates.

Lane BR, Golan S, Eggener S, Tobert CM, Kahnoski RJ, Kutikov A, Smaldone M, Whelan CM, Shalhav A, Uzzo RG.

J Urol. 2013 Jun;189(6):2047-53. doi: 10.1016/j.juro.2013.01.007. Epub 2013 Jan 9.


Expression of the PTTG1 oncogene is associated with aggressive clear cell renal cell carcinoma.

Wondergem B, Zhang Z, Huang D, Ong CK, Koeman J, Hof DV, Petillo D, Ooi A, Anema J, Lane B, Kahnoski RJ, Furge KA, Teh BT.

Cancer Res. 2012 Sep 1;72(17):4361-71. doi: 10.1158/0008-5472.CAN-11-2330. Epub 2012 Jul 17.


RENAL nephrometry score predicts surgery type independent of individual surgeon's use of nephron-sparing surgery.

Tobert CM, Kahnoski RJ, Thompson DE, Anema JG, Kuntzman RS, Lane BR.

Urology. 2012 Jul;80(1):157-61. doi: 10.1016/j.urology.2012.03.025. Epub 2012 May 23.


Increasing use of kidney sparing approaches for localized renal tumors in a community based health system: impact on renal functional outcomes.

Lane BR, Chen H, Morrow M, Anema JG, Kahnoski RJ.

J Urol. 2011 Oct;186(4):1229-35. doi: 10.1016/j.juro.2011.05.081. Epub 2011 Aug 17.


Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma.

Varela I, Tarpey P, Raine K, Huang D, Ong CK, Stephens P, Davies H, Jones D, Lin ML, Teague J, Bignell G, Butler A, Cho J, Dalgliesh GL, Galappaththige D, Greenman C, Hardy C, Jia M, Latimer C, Lau KW, Marshall J, McLaren S, Menzies A, Mudie L, Stebbings L, Largaespada DA, Wessels LF, Richard S, Kahnoski RJ, Anema J, Tuveson DA, Perez-Mancera PA, Mustonen V, Fischer A, Adams DJ, Rust A, Chan-on W, Subimerb C, Dykema K, Furge K, Campbell PJ, Teh BT, Stratton MR, Futreal PA.

Nature. 2011 Jan 27;469(7331):539-42. doi: 10.1038/nature09639. Epub 2011 Jan 19. Erratum in: Nature. 2012 Apr 5;484(7392):130.


Changes in specific domains of sexual function and sexual bother after radical prostatectomy.

Le JD, Cooperberg MR, Sadetsky N, Hittelman AB, Meng MV, Cowan JE, Latini DM, Carroll PR; CaPSURE Investigators.

BJU Int. 2010 Oct;106(7):1022-9. doi: 10.1111/j.1464-410X.2010.09231.x. Epub 2010 Feb 23.


Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes.

Dalgliesh GL, Furge K, Greenman C, Chen L, Bignell G, Butler A, Davies H, Edkins S, Hardy C, Latimer C, Teague J, Andrews J, Barthorpe S, Beare D, Buck G, Campbell PJ, Forbes S, Jia M, Jones D, Knott H, Kok CY, Lau KW, Leroy C, Lin ML, McBride DJ, Maddison M, Maguire S, McLay K, Menzies A, Mironenko T, Mulderrig L, Mudie L, O'Meara S, Pleasance E, Rajasingham A, Shepherd R, Smith R, Stebbings L, Stephens P, Tang G, Tarpey PS, Turrell K, Dykema KJ, Khoo SK, Petillo D, Wondergem B, Anema J, Kahnoski RJ, Teh BT, Stratton MR, Futreal PA.

Nature. 2010 Jan 21;463(7279):360-3. doi: 10.1038/nature08672. Epub 2010 Jan 6.


Microarray gene expression profiling using core biopsies of renal neoplasia.

Rogers CG, Ditlev JA, Tan MH, Sugimura J, Qian CN, Cooper J, Lane B, Jewett MA, Kahnoski RJ, Kort EJ, Teh BT.

Am J Transl Res. 2009 Jan 1;1(1):55-61.


Activation of the PI3K/AKT pathway induces urothelial carcinoma of the renal pelvis: identification in human tumors and confirmation in animal models.

Qian CN, Furge KA, Knol J, Huang D, Chen J, Dykema KJ, Kort EJ, Massie A, Khoo SK, Vanden Beldt K, Resau JH, Anema J, Kahnoski RJ, Morreau H, Camparo P, Comperat E, Sibony M, Denoux Y, Molinie V, Vieillefond A, Eng C, Williams BO, Teh BT.

Cancer Res. 2009 Nov 1;69(21):8256-64. doi: 10.1158/0008-5472.CAN-09-1689. Epub 2009 Oct 20.


Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer.

van Haaften G, Dalgliesh GL, Davies H, Chen L, Bignell G, Greenman C, Edkins S, Hardy C, O'Meara S, Teague J, Butler A, Hinton J, Latimer C, Andrews J, Barthorpe S, Beare D, Buck G, Campbell PJ, Cole J, Forbes S, Jia M, Jones D, Kok CY, Leroy C, Lin ML, McBride DJ, Maddison M, Maquire S, McLay K, Menzies A, Mironenko T, Mulderrig L, Mudie L, Pleasance E, Shepherd R, Smith R, Stebbings L, Stephens P, Tang G, Tarpey PS, Turner R, Turrell K, Varian J, West S, Widaa S, Wray P, Collins VP, Ichimura K, Law S, Wong J, Yuen ST, Leung SY, Tonon G, DePinho RA, Tai YT, Anderson KC, Kahnoski RJ, Massie A, Khoo SK, Teh BT, Stratton MR, Futreal PA.

Nat Genet. 2009 May;41(5):521-3. doi: 10.1038/ng.349. Epub 2009 Mar 29.


Somatic pairing of chromosome 19 in renal oncocytoma is associated with deregulated EGLN2-mediated [corrected] oxygen-sensing response.

Koeman JM, Russell RC, Tan MH, Petillo D, Westphal M, Koelzer K, Metcalf JL, Zhang Z, Matsuda D, Dykema KJ, Houseman HL, Kort EJ, Furge LL, Kahnoski RJ, Richard S, Vieillefond A, Swiatek PJ, Teh BT, Ohh M, Furge KA.

PLoS Genet. 2008 Sep 5;4(9):e1000176. doi: 10.1371/journal.pgen.1000176. Erratum in: PLoS Genet. 2008 Jul;4(7). doi: 10.1371/annotation/7f57058f-cc02-45a6-bfab-a835619e3916.


Identification of copy number alterations and its association with pathological features in clear cell and papillary RCC.

Matsuda D, Khoo SK, Massie A, Iwamura M, Chen J, Petillo D, Wondergem B, Avallone M, Kloostra SJ, Tan MH, Koeman J, Zhang Z, Kahnoski RJ; French Kidney Cancer Study Group, Baba S, Teh BT.

Cancer Lett. 2008 Dec 18;272(2):260-7. doi: 10.1016/j.canlet.2008.06.015. Epub 2008 Aug 3.


Prostate cancer outcomes among older men: insurance status comparisons results from CaPSURE database.

Sadetsky N, Elkin EP, Latini DM, DuChane J, Carroll PR; CaPSURE Investigators.

Prostate Cancer Prostatic Dis. 2008;11(3):280-7. Epub 2007 Sep 25.


Fear of recurrence, treatment satisfaction, and quality of life after radical prostatectomy for prostate cancer.

Hart SL, Latini DM, Cowan JE, Carroll PR; CaPSURE Investigators.

Support Care Cancer. 2008 Feb;16(2):161-9. Epub 2007 Jul 19.


Quality of life in young men after radical prostatectomy.

Wright JL, Lin DW, Cowan JE, Carroll PR, Litwin MS; CaPSURE Investigators.

Prostate Cancer Prostatic Dis. 2008;11(1):67-73. Epub 2007 May 22.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk